MAIOLINO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 5.391
AS - Asia 1.943
EU - Europa 1.270
AF - Africa 446
SA - Sud America 368
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 21
Totale 9.489
Nazione #
US - Stati Uniti d'America 5.165
SG - Singapore 795
CN - Cina 373
IT - Italia 225
HK - Hong Kong 221
BR - Brasile 218
SE - Svezia 121
DE - Germania 120
FI - Finlandia 95
VN - Vietnam 95
GB - Regno Unito 78
PL - Polonia 74
FR - Francia 54
NL - Olanda 54
RU - Federazione Russa 54
IN - India 45
UA - Ucraina 43
EC - Ecuador 22
AZ - Azerbaigian 21
CA - Canada 21
IQ - Iraq 21
TR - Turchia 21
HN - Honduras 20
PY - Paraguay 20
AT - Austria 19
CO - Colombia 19
JM - Giamaica 19
PT - Portogallo 19
AE - Emirati Arabi Uniti 18
PA - Panama 18
UZ - Uzbekistan 18
ZA - Sudafrica 18
CH - Svizzera 17
CV - Capo Verde 17
CY - Cipro 17
MA - Marocco 17
TN - Tunisia 17
AR - Argentina 16
BG - Bulgaria 16
BZ - Belize 16
CL - Cile 16
GE - Georgia 16
MD - Moldavia 16
BA - Bosnia-Erzegovina 15
BJ - Benin 15
CI - Costa d'Avorio 15
GA - Gabon 15
SO - Somalia 15
XK - ???statistics.table.value.countryCode.XK??? 15
AO - Angola 14
BS - Bahamas 14
ES - Italia 14
KG - Kirghizistan 14
KH - Cambogia 14
MY - Malesia 14
PS - Palestinian Territory 14
SA - Arabia Saudita 14
AL - Albania 13
AU - Australia 13
CU - Cuba 13
DZ - Algeria 13
EE - Estonia 13
IE - Irlanda 13
IR - Iran 13
LB - Libano 13
MG - Madagascar 13
ML - Mali 13
NO - Norvegia 13
PK - Pakistan 13
SI - Slovenia 13
SK - Slovacchia (Repubblica Slovacca) 13
BF - Burkina Faso 12
BO - Bolivia 12
BY - Bielorussia 12
GF - Guiana Francese 12
GN - Guinea 12
KR - Corea 12
LU - Lussemburgo 12
LV - Lettonia 12
LY - Libia 12
MR - Mauritania 12
NP - Nepal 12
PH - Filippine 12
UG - Uganda 12
UY - Uruguay 12
BE - Belgio 11
CG - Congo 11
CR - Costa Rica 11
CZ - Repubblica Ceca 11
DO - Repubblica Dominicana 11
GR - Grecia 11
HU - Ungheria 11
MX - Messico 11
PG - Papua Nuova Guinea 11
RS - Serbia 11
SD - Sudan 11
VE - Venezuela 11
ZW - Zimbabwe 11
AD - Andorra 10
DJ - Gibuti 10
Totale 9.020
Città #
Fairfield 885
Ashburn 526
Woodbridge 454
Singapore 443
Chandler 361
Houston 341
Seattle 321
Ann Arbor 296
Cambridge 268
Wilmington 267
Hong Kong 208
Santa Clara 153
Beijing 114
Boardman 106
Jacksonville 97
Princeton 81
San Diego 76
Padova 72
Medford 57
Roxbury 53
Bytom 52
Helsinki 46
Des Moines 44
Munich 41
Los Angeles 37
Nanjing 37
New York 37
Dong Ket 35
Buffalo 24
Ho Chi Minh City 23
Jinan 19
Baku 18
Guangzhou 18
London 18
Tashkent 17
Panama City 16
Chicago 15
Abidjan 14
Libreville 14
Milan 14
Bishkek 13
Havana 13
Phnom Penh 13
Praia 13
São Paulo 13
Conakry 12
Cotonou 12
Dublin 12
Nassau 12
Tallinn 12
Tbilisi 12
Hanoi 11
Luanda 11
Nouakchott 11
Pristina 11
Turku 11
Bamako 10
Castries 10
Dili 10
Falkenstein 10
Hebei 10
Kampala 10
Nairobi 10
San José 10
Tripoli 10
Ulan Bator 10
Vienna 10
Andorra la Vella 9
Baghdad 9
Boston 9
Changsha 9
Council Bluffs 9
Dakar 9
Hargeisa 9
Hefei 9
Kigali 9
Kingston 9
Managua 9
Montevideo 9
Ouagadougou 9
Port Moresby 9
Riga 9
Rome 9
Shenyang 9
Sofia 9
Amman 8
Antananarivo 8
Asunción 8
Atlanta 8
Cayenne 8
Chisinau 8
Djibouti 8
Harare 8
Istanbul 8
Khartoum 8
Limassol 8
Lisbon 8
Maputo 8
Melbourne 8
Nuremberg 8
Totale 6.302
Nome #
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy 354
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 239
Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy 219
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 211
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 196
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 190
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 189
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 188
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 187
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 186
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 176
Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism 174
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 169
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 168
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 168
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 165
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 157
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 157
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women 155
Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA study 155
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 154
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 154
Atrial fibrillation as presenting sign of primary aldosteronism: Results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study 153
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 152
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 151
Cure with cryoablation of arterial hypertension due to a renin-producing tumor. 151
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 149
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients 146
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble 145
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 139
Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects 137
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 137
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 137
Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in KCNJ5 Mutated Adenoma Cells Ex Vivo 135
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 135
The T-786 C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in caucasian patients of the GENICA study 131
Oxidative stress in hypertension and cardiovascular-renal remodeling:focus on the renin-angiotensin-aldosterone system 130
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives 128
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 128
Recent advances in the diagnosis and management of obstructive sleep apnea 125
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. 122
Adrenal Venous Sampling: Where Do We Stand? 122
The cardiovascular consequences of hyperaldosteronism 122
Primary aldosteronism in elderly, old, and very old patients 120
To reconsider (limit) the use of phosphate based food and beverages additives. A real need for health preservation. 118
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 118
Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives 116
Is there an increased heme oxygenase-1 behind the antioxidant effects of green tea on blood pressure and sympathoexcitation reduction? 116
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 116
Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension 114
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 106
Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients 106
Comparative study at computed tomography angiography and intravascular ultrasound of coronary atherosclerotic plaques 105
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 103
Magnesium, cardiovascular-renal disease and the Gitelman's syndrome paradox. 102
Arterial Hypertension, Aldosterone, and Atrial Fibrillation 101
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 101
New insights on the renal protective effects of mineralocorticoid receptor antagonists. 100
The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension. 99
Excess arterial damage in hyperaldosteronism: Further evidence from pressure wave analysis 97
Moderate-to-severe ischeamic mitral regurgitation and multivessel coronary artery disease: impact of different treatment on survival and rehospitalization 91
-786C and G894T variants of the Endothelial Nitric Oxide Synthase Gene and training-induced correction of endothelial dysfunction in coronary artery disease patients. 89
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines! 89
Survival and rehospitalization in patients with severe ischemic mitral regurgitation and multivessel coronary artery disease undergoing different treatment 88
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 87
International multicenter survey on screening and confirmatory testing in primary aldosteronism 79
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 73
The Molecular Basis of the Interplay Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation 70
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure 69
Fosfolipasi A2 associata alle lipoproteine ed eventi cardiovascolari 11
Mineralocorticoid receptor antagonism as an add-on treatment for resistant hypertension 5
Do Meta-Analyses of Association Studies of Endothelial Nitric Oxide Synthase (eNOS) Variants and Ischaemic Heart Disease Provide Conclusive Answers? 4
Nocturnal blood pressure: pathophysiology, measurement and clinical implications. Position paper of the European Society of Hypertension 2
Cardiovascular Implications of Sleep Disorders Beyond Sleep Apnea 2
Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors [1] (multiple letters) 2
Intra-atrial course of right coronary artery: A case report 2
Editorial: Sleep disorders, hypertension and cardiovascular diseases 2
Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling 2
Cross-sectional and longitudinal positive remodeling after subintimal drug-eluting stent implantation: multiple late coronary aneurysms, stent fractures, and a newly formed stent gap between previously overlapped stents 2
Assessing Lateralization Index of Adrenal Venous Sampling for Surgical Indication in Primary Aldosteronism 2
Risk factors and pharmacological therapy in patients with vascular disease 2
Computed tomography of the heart 2
Screening dell'ipertensione: preparazione del paziente e utilizzo dell'ARR-app 2
Non-invasive imaging of the coronary arteries 2
Calling for Action: The Need of Large-Scale Cohorts to Uncover the Cardiovascular Risk in Non-Sleepy Obstructive Sleep Apnea 2
Drug-resistant hypertension: An intriguing case 1
Treating sleep disorders to improve blood pressure control and cardiovascular prevention: A dream come true?—a narrative review 1
Totale 9.607
Categoria #
all - tutte 30.872
article - articoli 29.758
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 436
Totale 61.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021941 0 0 0 0 33 40 87 86 120 300 99 176
2021/2022959 13 90 88 83 92 79 51 102 53 25 73 210
2022/2023708 142 82 26 81 104 84 6 52 86 13 25 7
2023/2024327 18 43 51 29 16 41 22 16 8 15 26 42
2024/20251.545 9 106 87 61 223 28 97 133 93 61 242 405
2025/20262.782 320 468 775 962 257 0 0 0 0 0 0 0
Totale 9.607